PROVIDENCE, RI - Ocean Biomedical (NASDAQ: OCEA) has announced research findings that show its immunotherapy candidates can work synergistically with tyrosine kinase inhibitors (TKIs), potentially ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ocean Biomedical , Inc. (NASDAQ:OCEA), a pharmaceutical company based in Providence, Rhode Island, disclosed the sale of unregistered equity securities in a recent filing with the Securities and ...

Short interest in Ocean Biomedical Inc (NASDAQ:OCEA) increased during the last reporting period, rising from 510.35K to 1.59M. This put 15.29% of the company's publicly available shares short.